All news

EMA consults on patient measures

Added: Friday 3 October 2014

The European Medicines Agency is consulting on the use of patient-reported outcome (PRO) measures in oncology research. The organisation has drafted a ‘reflection paper’ designed to prompt a public discussion on the value of PRO data in the development and regulation of cancer medicines. The deadline to respond to the consultation is 30 November 2014.